Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
Announcing ShieldTx™
An antibody masking technology for delivering on-epitope, on-tissue clinical candidates with enhanced safety and developability
Meet iBio
Watch our all-new video and learn about our focus, technology, and team.
iBio Reports Triple Milestone
Positive pre-clinical in vivo data for three immuno-oncology candidates
AI-Powered Precision Antibody Therapeutics
Epitope-Steering and Antibody Optimization for Accelerating Cancer Immunotherapies
Discovery Platform
FROM PRECISION ANTIBODY IDENTIFICATION AND OPTIMIZATION TO TAILORED BI-SPECIFICS
Therapeutic Pipeline
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Partner with iBio
License our discovery platform or collaborate with us to advance our high-value pipeline assets
Announcing
EngageTX™
a CD3-BASED T-CELL ENGAGER PANEL FOR
OPTIMIZING BI-SPECIFICS
Therapeutic Candidates
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
The Expertise Behind the AI
Meet the team driving iBio’s powerful tech stack for drug discovery
